Quantitative mass spectrometry-based proteomics for biomarker development in ovarian cancer

Keyphrases

• Ovarian Cancer 100%
• Biomarker Development 100%
• Mass Spectrometry Analysis 100%
• Quantitative Mass Spectrometry 100%
• Treatment Strategy 50%
• Mass Spectrometry 50%
• Platinum Resistance 50%
• Targeted Proteomics 50%
• Disease Progression 25%
• Clinical Translation 25%
• Effective Treatment 25%
• Disease Risk 25%
• Early Detection 25%
• Biomarker Discovery 25%
• Protein Biomarkers 25%
• Disease Biomarker 25%
• Diagnostic Tool 25%
• Sensitivity Specificity 25%
• Ovarian Cancer Biomarkers 25%
• Advanced Ovarian Cancer 25%
• Chasm 25%
• Cancer Experience 25%
• Biomarker Combination 25%
• Proteomics Methods 25%
• Advanced Stage Disease 25%
• Short Life Expectancy 25%
• Biological Diagnostic 25%
• Proteomic Approach 25%
• Gynecologic Malignancies 25%
• Platinum-refractory Disease 25%

Medicine and Dentistry

• Biological Marker 100%
• Ovarian Cancer 100%
• Proteomics 100%
• Mass Spectrum 100%
• Disease 33%
• Diagnosis 16%
• Disease Exacerbation 16%
• Cancer 16%
• Tumor Marker 16%
• Reproducibility 16%
• Life Expectancy 16%
• Sensitivity and Specificity 16%

Biochemistry, Genetics and Molecular Biology

• Proteomics 100%
• Mass Spectrometry 100%
• Solution and Solubility 33%
• Biomarker Discovery 33%
• Life Expectancy 33%
• Tumor Marker 33%